- Filed
- Feb 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 24, 2025 | 23.81M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $26.89M |
| Current Assets | FY 2024 · Dec 31, 2023 | $209.37M |
| Total Assets | FY 2024 · Dec 31, 2023 | $304.09M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 23.17M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $6.79M |
| Capex | FY 2024 · Dec 31, 2022 | $3.5M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $6.92M |
| Cash And Equivalents restated | FY 2024 · Dec 31, 2022 | $20.12M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$1.00 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$1.00 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $14.18M |
| Rd Expense restated | FY 2024 · Dec 31, 2022 | $70.32M |
| Net Income | FY 2024 · Dec 31, 2022 | −$23.18M |
| Operating Income restated | FY 2024 · Dec 31, 2022 | $3.9M |
| Gross Profit restated | FY 2024 · Dec 31, 2022 | $105.45M |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2022 | $15.13M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2021 | $276.73M |